Key result
The third-generation laser balloon significantly reduced median procedure time to 77 minutes compared to 91 minutes with the second-generation device, while maintaining 100% acute isolation success.
Why the study?
Relatively long procedural duration was a strong limitation of the second-generation laser balloon, leading to the development of the third-generation laser balloon offering automized ablation for rapid PVI.
Does the third-generation laser balloon reduce procedure time compared to the second-generation laser balloon in patients undergoing pulmonary vein isolation?
Observational (n=30)
No
Does the third-generation laser balloon reduce procedure time compared to the second-generation laser balloon in patients undergoing pulmonary vein isolation?
The third-generation laser balloon significantly reduces procedure time, left atrial dwelling time, and total laser time compared to the second-generation device while maintaining safety and efficacy for pulmonary vein isolation.
BACKGROUND: Balloon-based ablation systems for pulmonary vein isolation (PVI) are providing procedural safety and efficacy as well as favourable clinical outcome. Although second-generation laser balloon (LB2) based PVI has been shown safety and efficacy relatively long procedural duration was a strong limitation. The third-generation laser balloon (LB3) offers and automized ablation for rapid PVI. We determined safety, efficacy and procedural characteristics of this new promising ablation system. METHODS AND RESULTS: A total of 15 consecutive patients were prospectively enrolled. All patients underwent PVI using the LB3. A total 59/59 PVs (100%) were successfully isolated. Procedural data was compared to the last 15 consecutive patients treated by the LB2. The median procedure time significantly declined from LB2 (91 (86, 105) min) to LB3 (77 (68, 87) min), p < 0.001. Similarly, the median left atrial dwelling time significantly decreased from LB2 (72 (62, 84) min) to LB3 (45 (38, 52) min), p < 0.0001. The total laser time decreased from LB2 (1920 (1765, 2193) sec) to LB3 (1077 (896, 1165) sec), p < 0.00001. A pure single shot PVI was performed in 18/59 PVs (31%). For major adverse events no differences were detected between the groups (LB2 1/15 (6.7%) and LB3 1/15 (6.7%), p = 0.999). CONCLUSION: The LB3 was safe and effective for PVI. Procedure time, LA dwelling time and total laser time significantly decreased compared to LB2.
No takes yet. Share an insight, caveat, or question.
Heeger et al. (2020) conducted an observational in Symptomatic drug-refractory paroxysmal or persistent atrial fibrillation (n=30). Third-generation laser balloon (LB3) vs. Second-generation laser balloon (LB2) was evaluated on Median procedure time (minutes) (p=<0.001). The third-generation laser balloon significantly reduced median procedure time to 77 minutes compared to 91 minutes with the second-generation device, while maintaining 100% acute isolation success.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: